Why Fed's Beth Hammack is not in favor of latest 25bps rate cut [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
However, not all members of the Federal Open Market Committee (FOMC) were in agreement with this move. Cleveland Fed President Beth Hammack dissented, advocating for keeping rates steady rather than implementing a cut. Yahoo Finance Fed reporter Jennifer Schonberger explores Hammack's reasoning, highlighting her concerns that the central bank still has more work to do in addressing inflation and bringing it down to its 2% target. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here This post was written by Angel Smith Related Videos November PCE data shows inflation cooling slightly Yahoo Finance Video • 15 minutes ago Novo Nordisk stock plunges on obesity shot trial results Yahoo Finance Video • 21 minutes ago November PCE, govt. shutdown looms, Novo Nordisk: 3 Things Yahoo Finance Video • 45 minutes ago Bitcoin is 'the right asset' to combat the US deficit: Sen. Lummis Yahoo Finance Video • 14 hours ago V
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- FDA approves Alhemo® injection as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B with inhibitors [Yahoo! Finance]Yahoo! Finance
- Eli Lilly's obesity drug Zepbound gains approval to treat sleep apnea [USA TODAY]USA TODAY
- Why Viking Therapeutics Tumbled by More Than 10% This Week [Yahoo! Finance]Yahoo! Finance
- Stock market today: Dow, S&P 500, Nasdaq rebound on fresh inflation data to cap volatile week [Yahoo! Finance Canada]Yahoo! Finance Canada
- Yahoo Finance [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 11/7/24 - Beat
NVO
Sec Filings
- 12/20/24 - Form 6-K
- 12/20/24 - Form 6-K
- 12/18/24 - Form 6-K
- NVO's page on the SEC website